Literature DB >> 2924312

Oxidative damage in murine tumor cells treated in vitro by recombinant human tumor necrosis factor.

R J Zimmerman1, A Chan, S A Leadon.   

Abstract

Treatment of three murine tumor cell lines, L929, P388, and Pan-02, in vitro with recombinant human tumor necrosis factor (rhTNF) produced evidence of oxidative damage as measured by (a) increases in intracellular glutathione levels, (b) the formation of intracellular oxidized glutathione and (c) the formation of thymine glycols in DNA. L929, the most sensitive of the three cell lines to the cytotoxic activity of rhTNF, had the lowest total glutathione content and was observed to have the highest levels of oxidized glutathione and thymine glycol formation. In addition, the radical buffering capacity of these cells was significantly compromised within 7 h of treatment with rhTNF. The P388 and Pan-02 cell lines, with total glutathione levels about 50-fold higher than L929, also showed evidence of oxidative attack, although to a lesser extent than L929. The radical buffering capacity of these cell lines was not altered by rhTNF treatment. A rhTNF-resistant subline of L929 (L929r), produced by successive passaging in vitro in the presence of TNF, increased its glutathione and oxidized glutathione levels in response to a subsequent rhTNF challenge. Meth A, a cell line resistant to rhTNF in vitro but not in vivo, showed no evidence of oxidative damage following rhTNF treatment, despite having a low radical scavenging capacity and a sensitivity to H2O2. The results with Meth A suggest that the interaction of rhTNF with this cell line does not occur in the same manner as the other cell lines, perhaps due to receptor differences or to some type of "uncoupling" of the signal-response network between the TNF receptor and a putative secondary messenger(s). These results are consistent with the hypothesis that: (a) the mechanism of action of rhTNF involves the production of oxidative damage, including damage to the DNA; (b) the sensitivity to rhTNF in vitro is related to the radical scavenging capacity of the cell; and (c) cells can respond to rhTNF challenge by increasing their free radical scavenging capacity.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2924312

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  26 in total

1.  Glutathione and the rate of cellular proliferation determine tumour cell sensitivity to tumour necrosis factor in vivo.

Authors:  E Obrador; J Navarro; J Mompo; M Asensi; J A Pellicer; J M Estrela
Journal:  Biochem J       Date:  1997-07-01       Impact factor: 3.857

2.  Effects of tumor-necrosis-factor-activated neutrophils on tumor cell survival.

Authors:  H Shau
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

3.  Increased tumor necrosis factor alpha mRNA after cellular exposure to ionizing radiation.

Authors:  D E Hallahan; D R Spriggs; M A Beckett; D W Kufe; R R Weichselbaum
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

4.  2nd International meeting on synovium cell biology, physiology and pathology. Canterbury, United Kingdom, 21-23 September 1994. Proceedings and abstracts.

Authors: 
Journal:  Ann Rheum Dis       Date:  1995-06       Impact factor: 19.103

Review 5.  Oxygen radicals, nitric oxide and human inflammatory joint disease.

Authors:  B Halliwell
Journal:  Ann Rheum Dis       Date:  1995-06       Impact factor: 19.103

6.  Response of multicellular tumor spheroids to liposomes containing TNF-alpha.

Authors:  F Weber; C Kremer; M Klinkhammer; B Rasier; M Brock
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

7.  Tumor necrosis factor-alpha-mediated decrease in glutathione increases the sensitivity of pulmonary vascular endothelial cells to H2O2.

Authors:  Y Ishii; C A Partridge; P J Del Vecchio; A B Malik
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

8.  Cell density plays a critical role in ex vivo expansion of T cells for adoptive immunotherapy.

Authors:  Qiangzhong Ma; Yawen Wang; Agnes Shuk-Yee Lo; Erica M Gomes; Richard P Junghans
Journal:  J Biomed Biotechnol       Date:  2010-06-30

9.  Superoxide Enhances the Antitumor Combination of AdMnSOD Plus BCNU in Breast Cancer.

Authors:  Wenqing G Sun; Christine J Weydert; Yuping Zhang; Lei Yu; Jingru Liu; Douglas R Spitz; Joseph J Cullen; Larry W Oberley
Journal:  Cancers (Basel)       Date:  2010-02-12       Impact factor: 6.639

10.  Sensitivity to tumour necrosis factor-mediated cytolysis is unrelated to manganous superoxide dismutase messenger RNA levels among transformed mouse fibroblasts.

Authors:  J M Boss; S M Laster; L R Gooding
Journal:  Immunology       Date:  1991-07       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.